Dysplastic nevus epidemiology and demographics

Dysplastic nevus Microchapters
Home
Patient Information
Overview
Classification
Pathophysiology
Causes
Differentiating Dysplastic nevus from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Dysplastic nevus epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Dysplastic nevus epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Dysplastic nevus epidemiology and demographics
CDC on Dysplastic nevus epidemiology and demographics
Dysplastic nevus epidemiology and demographics in the news
Blogs on Dysplastic nevus epidemiology and demographics
Directions to Hospitals Treating Dysplastic nevus
Risk calculators and risk factors for Dysplastic nevus epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Epidemiology and Demographics

Incidence

• The prevalence of any atypical nevi in white-skinned populations ranges from 2 to 10 percent.
• Some of the prevalence variation is explained by differences in the diagnostic criteria used.
• In patients with a personal history of melanoma, the estimated prevalence is 30 to 60 percent.  

Gender

Males are more commonly affected by dysplastic nevus compared to females.